- Home
- HIMS vs LNTH Comparison
HIMS vs LNTH Comparison
Compare HIMS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIMS
- LNTH
- Stock Information
- Founded
- HIMS 2017
- LNTH 1956
- Country
- HIMS United States
- LNTH United States
- Employees
- HIMS N/A
- LNTH N/A
- Industry
- HIMS Medical/Nursing Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HIMS Health Care
- LNTH Health Care
- Exchange
- HIMS Nasdaq
- LNTH Nasdaq
- Market Cap
- HIMS 9.0B
- LNTH 7.5B
- IPO Year
- HIMS N/A
- LNTH 2015
- Fundamental
- Price
- HIMS $27.71
- LNTH $95.58
- Analyst Decision
- HIMS Buy
- LNTH Strong Buy
- Analyst Count
- HIMS 12
- LNTH 6
- Target Price
- HIMS $38.75
- LNTH $129.83
- AVG Volume (30 Days)
- HIMS 22.6M
- LNTH 876.3K
- Earning Date
- HIMS 05-05-2025
- LNTH 05-01-2025
- Dividend Yield
- HIMS N/A
- LNTH N/A
- EPS Growth
- HIMS N/A
- LNTH N/A
- EPS
- HIMS 0.53
- LNTH 4.36
- Revenue
- HIMS $1,476,514,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- HIMS $56.79
- LNTH $6.59
- Revenue Next Year
- HIMS $18.10
- LNTH $11.80
- P/E Ratio
- HIMS $54.75
- LNTH $22.06
- Revenue Growth
- HIMS 69.33
- LNTH 18.32
- 52 Week Low
- HIMS $11.20
- LNTH $58.16
- 52 Week High
- HIMS $72.98
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- HIMS 36.82
- LNTH 47.07
- Support Level
- HIMS $31.88
- LNTH $94.80
- Resistance Level
- HIMS $38.69
- LNTH $100.73
- Average True Range (ATR)
- HIMS 2.90
- LNTH 3.65
- MACD
- HIMS -0.50
- LNTH -1.07
- Stochastic Oscillator
- HIMS 4.23
- LNTH 16.29
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.